company background image
CRM logo

PZ Cormay WSE:CRM Stock Report

Last Price

zł0.59

Market Cap

zł49.5m

7D

-2.0%

1Y

-26.5%

Updated

27 Mar, 2024

Data

Company Financials

CRM Stock Overview

PZ Cormay S.A. develops, manufactures, and sells diagnostic reagents in Poland.

CRM fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

PZ Cormay S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for PZ Cormay
Historical stock prices
Current Share Pricezł0.59
52 Week Highzł0.84
52 Week Lowzł0.55
Beta0.71
1 Month Change-8.13%
3 Month Change3.16%
1 Year Change-26.50%
3 Year Change-57.70%
5 Year Change-51.64%
Change since IPO-65.41%

Recent News & Updates

Fewer Investors Than Expected Jumping On PZ Cormay S.A. (WSE:CRM)

Sep 08
Fewer Investors Than Expected Jumping On PZ Cormay S.A. (WSE:CRM)

Recent updates

Fewer Investors Than Expected Jumping On PZ Cormay S.A. (WSE:CRM)

Sep 08
Fewer Investors Than Expected Jumping On PZ Cormay S.A. (WSE:CRM)

There's Been No Shortage Of Growth Recently For PZ Cormay's (WSE:CRM) Returns On Capital

Feb 27
There's Been No Shortage Of Growth Recently For PZ Cormay's (WSE:CRM) Returns On Capital

PZ Cormay (WSE:CRM) Is Experiencing Growth In Returns On Capital

Sep 15
PZ Cormay (WSE:CRM) Is Experiencing Growth In Returns On Capital

Shareholder Returns

CRMPL Medical EquipmentPL Market
7D-2.0%-0.08%2.1%
1Y-26.5%4.0%35.7%

Return vs Industry: CRM underperformed the Polish Medical Equipment industry which returned 4% over the past year.

Return vs Market: CRM underperformed the Polish Market which returned 35.7% over the past year.

Price Volatility

Is CRM's price volatile compared to industry and market?
CRM volatility
CRM Average Weekly Movement4.5%
Medical Equipment Industry Average Movement4.7%
Market Average Movement5.0%
10% most volatile stocks in PL Market9.6%
10% least volatile stocks in PL Market3.3%

Stable Share Price: CRM has not had significant price volatility in the past 3 months.

Volatility Over Time: CRM's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1985222Flavio Finotellohttps://cormay.com

PZ Cormay S.A. develops, manufactures, and sells diagnostic reagents in Poland. It offers testing products for clinical chemistry, electrophoresis, hematology, veterinary, coagulology, blood group serology, immunology, immunochemistry, molecular biology, sampling, oncological surgery, and general analytics, as well as vacuum blood collection system. The company offers its products under the Orphée and Diesse brand names.

PZ Cormay S.A. Fundamentals Summary

How do PZ Cormay's earnings and revenue compare to its market cap?
CRM fundamental statistics
Market capzł49.51m
Earnings (TTM)-zł5.08m
Revenue (TTM)zł84.06m

0.6x

P/S Ratio

-9.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CRM income statement (TTM)
Revenuezł84.06m
Cost of Revenuezł50.34m
Gross Profitzł33.72m
Other Expenseszł38.79m
Earnings-zł5.08m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Mar 29, 2024

Earnings per share (EPS)-0.06
Gross Margin40.11%
Net Profit Margin-6.04%
Debt/Equity Ratio0%

How did CRM perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.